干扰素α-2治疗降低骨髓增殖性肿瘤患者循环中性粒细胞胞外诱捕网水平
研究测量128例骨髓增殖性肿瘤(MPN)患者治疗前及85例治疗12个月后的血清中性粒细胞胞外诱捕网(NET)水平。基线NET与中性粒细胞计数、中性粒细胞与淋巴细胞比值及JAK2V617F等位基因负荷相关;聚乙二醇干扰素α-2a或α-2b分别使77%和73%患者NET下降,而羟基脲仅53%。
要点
- 基线NET水平与中性粒细胞计数、NLR及JAK2V617F等位基因负荷相关。
- PV中JAK2V617F等位基因负荷≥50%与NET水平升高相关(p=0.006)。
- 治疗12个月后,PEG-IFNα-2a和α-2b分别使77%和73%患者NET下降,羟基脲仅53%。
核心结论
- 基线NET水平与中性粒细胞计数、NLR和JAK2V617F等位基因负荷相关,干扰素α降低促血栓NET水平的效果优于羟基脲。
研究设计与样本
- 研究测量128例MPN患者治疗前血清NET样本及85例治疗12个月后的样本,治疗包括聚乙二醇干扰素α-2(PEG-IFNα-2)制剂或羟基脲(HU)。
主要发现
- 各亚诊断或表型驱动突变间NET水平无差异。
- PV中JAK2V617F+等位基因负荷≥50%与NET水平升高相关(p=0.006)。
- 基线NET水平与中性粒细胞计数(r=0.29,p=0.001)、中性粒细胞与淋巴细胞比值(r=0.26,p=0.004)及JAK2V617F等位基因负荷(r=0.22,p=0.03)相关。
- 在PV且等位基因负荷≥50%患者中,NET水平与中性粒细胞计数(r=0.50,p=0.01)、NLR(r=0.56,p=0.002)及JAK2V617F等位基因负荷(r=0.45,p=0.03)相关。
- PV治疗12个月后,等位基因负荷≥50%患者NET平均下降60%,而等位基因负荷<50%患者仅下降36%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neutrophil extracellular traps (NETs) may play a pathogenic role in the thrombosis associated with myeloproliferative neoplasms (MPNs). We measured serum NET levels in 128 pretreatment samples from patients with MPNs and in 85 samples taken after 12 months of treatment with interferon alpha-2 (PEG-IFNα-2) formulations or hydroxyurea (HU). No differences in NET levels were observed across subdiagnoses or phenotypic driver mutations. In PV, a JAK2V617F+ allele burden ≥50% associated with increased NET levels (p = 0.006). Baseline NET levels correlated with neutrophil count (r = 0.29, p = 0.001), neutrophil-to-lymphocyte ratio (r = 0.26, p = 0.004) and JAK2V617F allele burden (r = 0.22, p = 0.03), particularly in patients with PV and with allele burden ≥50% (r = 0.50, p = 0.01, r = 0.56, p = 0.002 and r = 0.45, p = 0.03 respectively). In PV, after 12 months of treatment, NET levels decreased on average by 60% in patients with allele burden ≥50%, compared to only 36% in patients with an allele burden <50%. Overall, treatment with PEG-IFNα-2a or PEG-IFNα-2b reduced NETs levels in 77% and 73% of patients, respectively, versus only 53% of HU-treated patients (average decrease across treatments: 48%). Normalization of blood counts did not per se account for these reductions. In conclusion, baseline NET levels correlated with neutrophil count, NLR and JAK2V617F allele burden, and IFNα was more effective at reducing prothrombotic NET levels than HU.
引用
- Massarenti L, Knudsen TA, Enevold C, et al. Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms. Br J Haematol. 2023. PMID: 37211985. doi:10.1111/bjh.18845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。